Related Experiment Videos
Thrombolytic therapy
M S Eisenberg1, R V Aghababian, L Bossaert
1University of Washington, Seattle.
Insights
Patients with acute myocardial infarction (AMI) symptoms and ECG findings should be evaluated for thrombolytic therapy. Clinical judgment considering risks, benefits, and contraindications is crucial for effective treatment.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Acute myocardial infarction (AMI) requires prompt intervention.
- Thrombolytic therapy is a key treatment option for AMI.
- Clinical decision-making for thrombolysis involves risk-benefit assessment.
Purpose of the Study:
- To outline criteria and protocols for thrombolytic therapy in AMI.
- To emphasize the importance of timely treatment administration.
- To guide healthcare professionals in managing AMI patients.
Main Methods:
- Review of clinical guidelines for AMI management.
- Emphasis on physician's clinical judgment.
- Development of written protocols for prehospital and emergency department care.
- Standardization of treatment time intervals.
Main Results:
- Thrombolytic therapy should be considered for all eligible AMI patients.
- Physician's judgment is paramount, considering contraindications, patient age, and symptom duration.
- Standardized protocols can improve patient care and reduce treatment times.
- A 30-60 minute treatment window from ED arrival to drug administration is achievable.
Conclusions:
- Prompt consideration and administration of thrombolytic therapy are vital for AMI.
- Established protocols and clinical judgment are essential for optimal patient outcomes.
- Continuous monitoring and improvement of treatment procedures are necessary.
Abstract:
All patients with symptoms and ECG findings suggestive of acute myocardial infarction (AMI) should be considered for treatment with thrombolytic agents. The decision to use thrombolytic therapy is a clinical judgment based upon a weighing of the potential benefits versus the possible risks. The physician must take into account relative contraindications, age of the patient, area of jeopardized myocardium, and duration of symptoms. Health professionals involved in the care of AMI patients should develop written plans and protocols addressing the following matters: identification of patients with chest pain in the prehospital setting (this applies to hospitals that receive patients from emergency medical services systems), triage of patients in the emergency department, obtaining the 12-lead electrocardiogram, determination of contraindications, authority for ordering thrombolytic therapy, and consultation for atypical cases. There also should be agreed standards for the time interval from arrival in the ED to administration of the thrombolytic agent, as well as a commitment to the prospective monitoring of procedures and times to assure continuous improvement. A time interval for treatment (arrival in ED to administration of drug) of 30 to 60 minutes should be achievable for patients who present with typical symptoms and ECG findings.